Our findings show an overall trend of consistently lower anti-spike IgG levels in individuals with hematological cancers across multiple doses and different timepoints following vaccination compared to healthy individuals, indicating impaired immune responses to the COVID-19 vaccines.
← all excerpts
Circulating SARS-CoV-2 spike IgG antibody responses in cancer patients following multiple COVID-19 vaccination boosters.
1
—
—